up and up gentle laxative tablets

Manufacturer
Target Corporation
Effective date
2025-11-04
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
full-release
Hydrated at
2026-06-01 01:41:57

Label at a glance#

Productup and up gentle laxative
Active ingredientBISACODYL
Label structure8 sections

Indications and uses

for temporary relief of occasional constipation and irregularity this product generally produces bowel movement in 6 to 12 hours

Dosage and administration

take with a glass of water  adults and children 12 years of age and over  take 1 to 3 tablets in a single daily dose  children 6 to under 12 years of age  take 1 tablet in a single daily dose  children under 6 years of age  ask a doctor

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Bisacodyl, USP 5 mg

Purpose

OTC - PURPOSE SECTION

Stimulant laxative

Uses

INDICATIONS & USAGE SECTION

  • for temporary relief of occasional constipation and irregularity
  • this product generally produces bowel movement in 6 to 12 hours

Warnings

WARNINGS SECTION

Do not use

OTC - DO NOT USE SECTION

if you cannot swallow without chewing

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • stomach pain, nausea or vomiting
  • a sudden change in bowel habits that lasts more than 2 weeks

When using this product

OTC - WHEN USING SECTION

  • do not chew or crush tablet(s)
  • it may cause stomach discomfort, faintness and cramps
  • do not use within 1 hour after taking an antacid or milk

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you have rectal bleeding or no bowel movement after using this product.  These could be signs of a serious condition.
  • you need to use a laxative for more than 1 week

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

DOSAGE & ADMINISTRATION SECTION

take with a glass of water

 adults and children 12 years of age and over

 take 1 to 3 tablets in a single daily dose

 children 6 to under 12 years of age

 take 1 tablet in a single daily dose

 children under 6 years of age

 ask a doctor

Other information

SPL UNCLASSIFIED SECTION

  • store at 20°-25°C (68°-77°F)
  • Protect from excessive humidity

Inactive ingredients

INACTIVE INGREDIENT SECTION

acacia, anhydrous calcium sulfate, anhydrous lactose, carnauba wax, colloidal silicon dioxide, corn starch, D&C yellow #10 aluminum lake, FD&C yellow #6 aluminum lake, gelatin, iron oxide, iron oxide black, iron oxide yellow, magnesium stearate, microcrystalline cellulose, polyethylene glycol (PEG)400, polyvinyl acetate phthalate, povidone, shellac, sodium starch glycolate, stearic acid, sugar, talc, titanium dioxide.

Questions?

OTC - QUESTIONS SECTION

Call 1-800-910-6874

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 11673-116-25

Compareto active ingredient in Dulcolax®*

gentle laxative tablets

bisacodyl USP, 5 mg

gentle, overnight relief of constipation

25 Tablets

25 COATED TABLETS

*This product is not manufactured or distributed by Boehringer Ingelheim Pharmaceuticals, Inc., the owner of the registered trademark of Dulcolax®

245 05 0371 R00 ID295403

Dist.by Target Corp., Mpls., MN 55403

©2015 Target Brands, Inc.

Shop Target.com

TAMPER- EVIDENT: DO NOT USE IF ANY INDIVIDUAL UNIT IS BROKEN OR OPEN

up and up gentle laxative tablets
up and up gentle laxative tablets

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
308753bisacodyl 5 MG Delayed Release Oral TabletPSN8
308753bisacodyl 5 MG Delayed Release Oral TabletSCD8
308753bisacodyl 5 MG Enteric Coated Oral TabletSY8

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
DEACETYLBISACODYL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20181113

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e2db08c6-133f-4f4f-afb4-e90a2418d6f6Product name120230320
11ed6f83-cdd2-4637-8379-b1a1d3ae3cdeProduct name120181101
86c45a79-b9f0-4476-a27c-6e10db098497Product name120180125
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11673-116-25up and up gentle laxative1 in 1 CARTONTABLET, COATED18
11673-116-25up and up gentle laxative25 in 1 BLISTER PACKTABLET, COATED258

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
11673-116-25EA - Each11673-1166d365ca3-d0f0-47e2-a6fb-a57920b3191712016-04-04

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 26 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11673-11611673-116-25

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 24 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
72024-11-07full-release2026-06-01 00:35:35

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
up and up gentle laxativeBISACODYLTarget Corporation4a29dc2b-b68f-471b-a84e-4a5096aa37482025-11-04WarningsExact identifier
ndc (package): 11673-116-25
ndc (product): 11673-116
ndc11 (package): 11673011625
spl id: 42c3027f-acc9-1014-e063-6294a90a5253
spl set id: 4a29dc2b-b68f-471b-a84e-4a5096aa3748

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.